Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $5.83 billion. The enterprise value is $7.61 billion.
| Market Cap | 5.83B |
| Enterprise Value | 7.61B |
Important Dates
The next estimated earnings date is Wednesday, July 23, 2025, before market open.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TMHC has 100.37 million shares outstanding. The number of shares has decreased by -3.93% in one year.
| Current Share Class | 100.37M |
| Shares Outstanding | 100.37M |
| Shares Change (YoY) | -3.93% |
| Shares Change (QoQ) | -2.09% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 99.27% |
| Float | 99.70M |
Valuation Ratios
The trailing PE ratio is 6.76 and the forward PE ratio is 7.47.
| PE Ratio | 6.76 |
| Forward PE | 7.47 |
| PS Ratio | 0.72 |
| Forward PS | 0.70 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | 15.25 |
| P/OCF Ratio | 13.95 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.75, with an EV/FCF ratio of 19.91.
| EV / Earnings | 8.40 |
| EV / Sales | 0.91 |
| EV / EBITDA | 5.75 |
| EV / EBIT | 5.93 |
| EV / FCF | 19.91 |
Financial Position
The company has a current ratio of 7.72, with a Debt / Equity ratio of 0.36.
| Current Ratio | 7.72 |
| Quick Ratio | 0.58 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.61 |
| Debt / FCF | 5.65 |
| Interest Coverage | 58.72 |
Financial Efficiency
Return on equity (ROE) is 15.97% and return on invested capital (ROIC) is 10.21%.
| Return on Equity (ROE) | 15.97% |
| Return on Assets (ROA) | 8.77% |
| Return on Invested Capital (ROIC) | 10.21% |
| Return on Capital Employed (ROCE) | 15.34% |
| Revenue Per Employee | $2.99M |
| Profits Per Employee | $323,752 |
| Employee Count | 2,800 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 1.00 |
Taxes
In the past 12 months, TMHC has paid $276.67 million in taxes.
| Income Tax | 276.67M |
| Effective Tax Rate | 23.33% |
Stock Price Statistics
The stock price has increased by +3.20% in the last 52 weeks. The beta is 1.57, so TMHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | +3.20% |
| 50-Day Moving Average | 57.91 |
| 200-Day Moving Average | 63.84 |
| Relative Strength Index (RSI) | 51.46 |
| Average Volume (20 Days) | 902,133 |
Short Selling Information
The latest short interest is 2.21 million, so 2.21% of the outstanding shares have been sold short.
| Short Interest | 2.21M |
| Short Previous Month | 2.16M |
| Short % of Shares Out | 2.21% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | 2.37 |
Income Statement
In the last 12 months, TMHC had revenue of $8.36 billion and earned $906.51 million in profits. Earnings per share was $8.60.
| Revenue | 8.36B |
| Gross Profit | 2.06B |
| Operating Income | 1.28B |
| Pretax Income | 968.08M |
| Net Income | 906.51M |
| EBITDA | 1.32B |
| EBIT | 1.28B |
| Earnings Per Share (EPS) | $8.60 |
Balance Sheet
The company has $377.82 million in cash and $2.16 billion in debt, giving a net cash position of -$1.78 billion or -$17.74 per share.
| Cash & Cash Equivalents | 377.82M |
| Total Debt | 2.16B |
| Net Cash | -1.78B |
| Net Cash Per Share | -$17.74 |
| Equity (Book Value) | 5.96B |
| Book Value Per Share | 59.15 |
| Working Capital | 6.84B |
Cash Flow
In the last 12 months, operating cash flow was $418.05 million and capital expenditures -$35.73 million, giving a free cash flow of $382.32 million.
| Operating Cash Flow | 418.05M |
| Capital Expenditures | -35.73M |
| Free Cash Flow | 382.32M |
| FCF Per Share | $3.81 |
Margins
Gross margin is 24.63%, with operating and profit margins of 15.35% and 10.84%.
| Gross Margin | 24.63% |
| Operating Margin | 15.35% |
| Pretax Margin | 14.18% |
| Profit Margin | 10.84% |
| EBITDA Margin | 15.82% |
| EBIT Margin | 15.35% |
| FCF Margin | 4.57% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.93% |
| Shareholder Yield | 3.93% |
| Earnings Yield | 15.55% |
| FCF Yield | 6.56% |
Analyst Forecast
The average price target for TMHC is $75.63, which is 30.20% higher than the current price. The consensus rating is "Buy".
| Price Target | $75.63 |
| Price Target Difference | 30.20% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMHC has an Altman Z-Score of 4.05 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.05 |
| Piotroski F-Score | 6 |